Skip to content

The use of Fospropofol disodium and Propofol Combined with Low-Dose Alfentanil in Gastrointestinal Endoscopy: A Randomized Controlled Study

The use of Fospropofol disodium and Propofol Combined with Low-Dose Alfentanil in Gastrointestinal Endoscopy: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111848
Enrollment
Unknown
Registered
2025-11-06
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal pain

Interventions

Fospropofol Disodium Group:Sedation with fospropofol disodium
Propofol Group:Propofol sedation

Sponsors

The People's Hospital of Fengqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old, < 65 years old; 2.BMI: 18-28 kg/m ²; 3.ASA classification I- II;

Exclusion criteria

Exclusion criteria: 1. Refuse to participate; 2. Severe diseases of vital organs such as the heart, liver, kidneys and lungs; 3. Allergic to benzodiazepines and long-term use of benzodiazepines; 4. Pregnant or lactating patients; 5. History of drug abuse or alcoholism; 6. There is a history of abnormal recovery from anesthesia and allergy to anesthetic drugs in the past; 7. Improve the Mallampati classification to level IV; 8. Other reasons why the researcher deems the patient unsuitable to participate in this study must be clearly and detailly recorded in the CRF.

Design outcomes

Primary

MeasureTime frame
Success rate of induction and sedation;

Secondary

MeasureTime frame
Additional Drug Administration Status;Satisfaction;Induction time;Emergence time;PACU stay time;Total Dosage of Fospropofol Disodium and Propofol;Vital Signs;

Countries

China

Contacts

Public ContactWangYanli

The People's Hospital of Fengqing

18314085190@163.com+86 883 421 5200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026